Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:862883rdf:typepubmed:Citationlld:pubmed
pubmed-article:862883lifeskim:mentionsumls-concept:C0042402lld:lifeskim
pubmed-article:862883pubmed:issue4lld:pubmed
pubmed-article:862883pubmed:dateCreated1977-7-18lld:pubmed
pubmed-article:862883pubmed:abstractTextA series of cis and trans N1-arylalkyl-N4-(2'-pyridyl)-2'6-dimethylpiperazines were synthetized and tested as adrenolytic and vasodilator agents. The N1-substitution with the 3,4-dimethoxyphenethyl group seems the most promising with regard to pharmacological activity, which was found to reside mainly in the trans isomer (3-II b). The adrenolytic activity of (3-II b) is comparable with that of the related 2-methyl derivative (1-III), while it is higher than that of (IV) in which the piperazine nucleus is C-unsubstituted.lld:pubmed
pubmed-article:862883pubmed:languageenglld:pubmed
pubmed-article:862883pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:862883pubmed:citationSubsetIMlld:pubmed
pubmed-article:862883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:862883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:862883pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:862883pubmed:statusMEDLINElld:pubmed
pubmed-article:862883pubmed:monthAprlld:pubmed
pubmed-article:862883pubmed:issn0430-0920lld:pubmed
pubmed-article:862883pubmed:authorpubmed-author:DorigottiLLlld:pubmed
pubmed-article:862883pubmed:authorpubmed-author:CignarellaGGlld:pubmed
pubmed-article:862883pubmed:authorpubmed-author:LorigaMMlld:pubmed
pubmed-article:862883pubmed:authorpubmed-author:PirisinoGGlld:pubmed
pubmed-article:862883pubmed:issnTypePrintlld:pubmed
pubmed-article:862883pubmed:volume32lld:pubmed
pubmed-article:862883pubmed:ownerNLMlld:pubmed
pubmed-article:862883pubmed:authorsCompleteYlld:pubmed
pubmed-article:862883pubmed:pagination296-302lld:pubmed
pubmed-article:862883pubmed:dateRevised2009-6-5lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-A...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-M...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-C...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-R...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-C...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-C...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-M...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-P...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-I...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-S...lld:pubmed
pubmed-article:862883pubmed:meshHeadingpubmed-meshheading:862883-V...lld:pubmed
pubmed-article:862883pubmed:year1977lld:pubmed
pubmed-article:862883pubmed:articleTitle2,6-dialkylpiperazines. VIII (1)-N1-arylalkyl-N4-(2'-pyridyl)-2,6-dimethylpiperazines as adrenolytic and vasodilator agents.lld:pubmed
pubmed-article:862883pubmed:publicationTypeJournal Articlelld:pubmed